Biorestorative Therapies (NASDAQ:BRTX) Trading 5.9% Higher – Here’s What Happened

Biorestorative Therapies, Inc. (NASDAQ:BRTX)’s stock price rose 5.9% during trading on Friday . The company traded as high as $0.2873 and last traded at $0.26. Approximately 45,434,601 shares changed hands during mid-day trading, an increase of 4,766% from the average daily volume of 933,692 shares. The stock had previously closed at $0.2455.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Biorestorative Therapies in a research note on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has an average rating of “Sell”.

Biorestorative Therapies Trading Up 5.9%

The stock has a fifty day simple moving average of $1.08 and a two-hundred day simple moving average of $1.33. The firm has a market cap of $2.31 million, a PE ratio of -0.18 and a beta of 0.39.

Biorestorative Therapies (NASDAQ:BRTX) last released its quarterly earnings data on Wednesday, November 12th. The company reported ($0.38) EPS for the quarter, meeting analysts’ consensus estimates of ($0.38). Biorestorative Therapies had a negative net margin of 3,308.09% and a negative return on equity of 231.08%. The company had revenue of $0.01 million during the quarter, compared to analyst estimates of $0.46 million. As a group, sell-side analysts predict that Biorestorative Therapies, Inc. will post -1.43 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Citadel Advisors LLC bought a new stake in shares of Biorestorative Therapies during the 3rd quarter worth $152,000. DRW Securities LLC purchased a new stake in Biorestorative Therapies during the fourth quarter valued at about $55,000. Finally, Virtu Financial LLC boosted its holdings in shares of Biorestorative Therapies by 102.4% in the 3rd quarter. Virtu Financial LLC now owns 24,351 shares of the company’s stock worth $35,000 after purchasing an additional 12,319 shares in the last quarter. Hedge funds and other institutional investors own 69.38% of the company’s stock.

Biorestorative Therapies Company Profile

Biorestorative Therapies Inc (NASDAQ: BRTX) is a clinical-stage biopharmaceutical company focused on the development and commercialization of regenerative tissue therapy products. The company leverages a proprietary universal allogeneic cell technology platform to create high-potency cell therapy candidates designed to promote tissue repair, reduce inflammation and accelerate healing in areas damaged by disease or medical treatment.

Its lead development program targets radiation-induced oral mucositis (RIOM), a painful and dose-limiting side effect experienced by head and neck cancer patients undergoing radiotherapy.